Clinical Study
Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease
Table 2
Serum IgG and IgG4 concentrations and IgG4/IgG4 ratio of patients with false-positive and false-negative diagnoses of IgG4-RD.
| False positives | | | |
| Diagnosis | IgG (mg/dL) | IgG4 (mg/dL) | IgG4/IgG |
| (1) MCD | 7,080 | 4,560 | 64.4% | (2) MCD | 4,420 | 690 | 15.6% | (3) B-cell lymphoma | 2,510 | 456 | 18.2% | (4) MCD | 2,960 | 295 | 10.0% | (5) MCD | 2,476 | 295 | 11.9% | (6) B-cell lymphoma | 4,010 | 271 | 6.8% | (7) Scleritis | 2,900 | 232 | 8.0% | (8) Sarcoidosis | 1,380 | 189 | 13.7% | (9) Sjögren’s syndrome | 3,920 | 171 | 4.4% | (10) Malignant lymphoma | 1,930 | 141 | 7.3% |
| False negatives | | | |
| Diagnosis | IgG(mg/dL) | IgG4(mg/dL) | IgG4/IgG |
| (1) IgG4-RD | 1,149 | 125 | 10.9% | (2) IgG4-RD | 1,210 | 123 | 10.2% | (3) IgG4-RD | 1,228 | 111 | 9.0% | (4) IgG4-RD | 1,260 | 106 | 8.4% |
|
|
IgG4-RD: IgG4-related disease; MCD: multicentric Castleman’s disease.
|